Primary Job Title CTO and Co-Founder Primary Organization ReGelTec
Location Greater Philadelphia Area, Pennsylvania, United States Regions Great Lakes, Northeastern US Gender Male Also Known As Tony Lowman
LinkedIn View on LinkedIn
Anthony M. (Tony) Lowman is the CTO and co-founder of ReGelTec, Inc. and has served as the Dean of the Henry M. Rowan College of Engineering and Professor of Biomedical and Chemical Engineering at Rowan University since 2013. His research contributions have focused on thepreparation, characterization and evaluation of the behavior of compatible,
crosslinked polymers known as hydrogels, which have been used as biocompatible materials in medical devices and controlled release devices for the delivery of peptides and proteins. He has published more than 100 refereed journal articles and book chapters, and has more than 20 US and worldwide patents issued. His work has attracted more than $20M funding from the Depts of Defense, Energy and Commerce, NIH, NSF, the Whitaker Foundation and private industry. He is a fellow of the National Academy of Inventors and the American Institute of Medical and Biological Engineers. He was previously honored as one of the top 100 Scientific Innovators in the world under the age of 35 as named by the MIT-Technology Review Magazine. Previously, Tony co-founded Gelifex, Inc., a company pursuing non-invasive methods for using hydrogels for repair of the nucleus pulposus of the intervertebral disc. Gelifex was acquired by Synthes in 2004. Previously, he has held academic appointments at Temple University and Drexel University. Tony received his education in chemical engineering at the University of Virginia (B.S., 1993) and at Purdue University (Ph.D., 1997).
